Order Article Reprints

Martin M, Pusceddu MM, Teichenné J, Negra T, Connolly A, Escoté X, Torrell Galceran H, Cereto Massagué A, Samarra Mestre I, del Pino Rius A, et al. Preventive Treatment with Astaxanthin Microencapsulated with Spirulina Powder, Administered in a Dose Range Equivalent to Human Consumption, Prevents LPS-Induced Cognitive Impairment in Rats. Nutrients. 2023; 15(13):2854. https://doi.org/10.3390/nu15132854

Martin, Miquel, Matteo M. Pusceddu, Joan Teichenné, Teresa Negra, Alan Connolly, Xavier Escoté, Helena Torrell Galceran, Adrià Cereto Massagué, Iris Samarra Mestre, Antoni del Pino Rius, and et al. 2023. "Preventive Treatment with Astaxanthin Microencapsulated with Spirulina Powder, Administered in a Dose Range Equivalent to Human Consumption, Prevents LPS-Induced Cognitive Impairment in Rats" Nutrients 15, no. 13: 2854. https://doi.org/10.3390/nu15132854

Martin, M., Pusceddu, M. M., Teichenné, J., Negra, T., Connolly, A., Escoté, X., Torrell Galceran, H., Cereto Massagué, A., Samarra Mestre, I., del Pino Rius, A., Romero-Gimenez, J., Egea, C., Alcaide-Hidalgo, J. M., & del Bas, J. M. (2023). Preventive Treatment with Astaxanthin Microencapsulated with Spirulina Powder, Administered in a Dose Range Equivalent to Human Consumption, Prevents LPS-Induced Cognitive Impairment in Rats. Nutrients, 15(13), 2854. https://doi.org/10.3390/nu15132854